annual CFF:
$20.52M+$325.77M(+106.72%)Summary
- As of today (September 1, 2025), JAZZ annual cash flow from financing activities is $20.52 million, with the most recent change of +$325.77 million (+106.72%) on December 31, 2024.
- During the last 3 years, JAZZ annual CFF has fallen by -$3.95 billion (-99.48%).
- JAZZ annual CFF is now -99.48% below its all-time high of $3.97 billion, reached on December 31, 2021.
Performance
JAZZ Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
-$124.53M+$688.94M(+84.69%)Summary
- As of today (September 1, 2025), JAZZ quarterly cash flow from financing activities is -$124.53 million, with the most recent change of +$688.94 million (+84.69%) on June 30, 2025.
- Over the past year, JAZZ quarterly CFF has increased by +$36.56 million (+22.70%).
- JAZZ quarterly CFF is now -102.67% below its all-time high of $4.66 billion, reached on June 30, 2021.
Performance
JAZZ quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
-$699.84M+$36.56M(+4.96%)Summary
- As of today (September 1, 2025), JAZZ TTM cash flow from financing activities is -$699.84 million, with the most recent change of +$36.56 million (+4.96%) on June 30, 2025.
- Over the past year, JAZZ TTM CFF has dropped by -$303.40 million (-76.53%).
- JAZZ TTM CFF is now -114.84% below its all-time high of $4.72 billion, reached on June 30, 2021.
Performance
JAZZ TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
JAZZ Cash from financing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +106.7% | +22.7% | -76.5% |
3 y3 years | -99.5% | -1255.5% | +28.0% |
5 y5 years | +107.0% | -119.4% | -280.6% |
JAZZ Cash from financing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -99.5% | +103.9% | -150.5% | +84.7% | -3511.2% | +28.0% |
5 y | 5-year | -99.5% | +103.9% | -102.7% | +84.7% | -114.8% | +28.0% |
alltime | all time | -99.5% | +103.9% | -102.7% | +84.7% | -114.8% | +28.0% |
JAZZ Cash from financing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | -$124.53M(-84.7%) | -$699.84M(-5.0%) |
Mar 2025 | - | -$813.47M(+9730.4%) | -$736.40M(-3689.4%) |
Dec 2024 | $20.52M(-106.7%) | -$8.28M(-103.4%) | $20.52M(-128.7%) |
Sep 2024 | - | $246.43M(-253.0%) | -$71.52M(-82.0%) |
Jun 2024 | - | -$161.09M(+184.8%) | -$396.44M(+19.4%) |
Mar 2024 | - | -$56.55M(-43.6%) | -$332.02M(+8.8%) |
Dec 2023 | -$305.25M(-42.3%) | -$100.31M(+27.8%) | -$305.25M(+64.7%) |
Sep 2023 | - | -$78.49M(-18.8%) | -$185.35M(-53.2%) |
Jun 2023 | - | -$96.67M(+224.5%) | -$395.91M(+37.2%) |
Mar 2023 | - | -$29.79M(-252.0%) | -$288.47M(-45.5%) |
Dec 2022 | -$529.49M(-113.3%) | $19.60M(-106.8%) | -$529.49M(-33.5%) |
Sep 2022 | - | -$289.05M(-2782.1%) | -$795.70M(-18.1%) |
Jun 2022 | - | $10.78M(-104.0%) | -$971.82M(-126.4%) |
Mar 2022 | - | -$270.81M(+9.8%) | $3.68B(-7.3%) |
Dec 2021 | $3.97B(+651.9%) | -$246.61M(-47.0%) | $3.97B(-7.1%) |
Sep 2021 | - | -$465.18M(-110.0%) | $4.27B(-9.4%) |
Jun 2021 | - | $4.66B(>+9900.0%) | $4.72B(+579.4%) |
Mar 2021 | - | $18.28M(-67.3%) | $694.03M(+31.4%) |
Dec 2020 | $528.07M(-279.8%) | $55.88M(-346.6%) | $528.07M(+37.4%) |
Sep 2020 | - | -$22.66M(-103.5%) | $384.42M(-0.8%) |
Jun 2020 | - | $642.53M(-535.1%) | $387.61M(-224.6%) |
Mar 2020 | - | -$147.68M(+68.2%) | -$311.08M(+5.9%) |
Dec 2019 | -$293.75M(-37.9%) | -$87.78M(+351.0%) | -$293.75M(-55.0%) |
Sep 2019 | - | -$19.46M(-65.3%) | -$652.42M(+0.8%) |
Jun 2019 | - | -$56.15M(-56.9%) | -$646.93M(+16.5%) |
Mar 2019 | - | -$130.35M(-70.8%) | -$555.50M(+17.5%) |
Dec 2018 | -$472.72M(+15.5%) | -$446.46M(+3095.4%) | -$472.72M(+613.5%) |
Sep 2018 | - | -$13.97M(-139.6%) | -$66.25M(+162.4%) |
Jun 2018 | - | $35.28M(-174.2%) | -$25.25M(-90.8%) |
Mar 2018 | - | -$47.58M(+19.0%) | -$275.01M(-32.8%) |
Dec 2017 | -$409.11M(-175.6%) | -$39.98M(-247.9%) | -$409.11M(-24.4%) |
Sep 2017 | - | $27.03M(-112.6%) | -$541.17M(-265.5%) |
Jun 2017 | - | -$214.48M(+18.1%) | $327.02M(-36.1%) |
Mar 2017 | - | -$181.67M(+5.6%) | $511.77M(-5.4%) |
Dec 2016 | $540.99M(-352.5%) | -$172.04M(-119.2%) | $540.99M(-8.2%) |
Sep 2016 | - | $895.23M(-3110.7%) | $589.24M(-247.2%) |
Jun 2016 | - | -$29.73M(-80.5%) | -$400.40M(+10.2%) |
Mar 2016 | - | -$152.46M(+23.2%) | -$363.45M(+69.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2015 | -$214.25M(-130.1%) | -$123.79M(+31.1%) | -$214.25M(+116.3%) |
Sep 2015 | - | -$94.42M(-1407.3%) | -$99.06M(-138.3%) |
Jun 2015 | - | $7.22M(-321.5%) | $258.63M(+22.0%) |
Mar 2015 | - | -$3.26M(-62.1%) | $211.95M(-70.3%) |
Dec 2014 | $712.88M(-3066.7%) | -$8.60M(-103.3%) | $712.88M(+2.9%) |
Sep 2014 | - | $263.27M(-767.3%) | $692.58M(+80.6%) |
Jun 2014 | - | -$39.45M(-107.9%) | $383.59M(-18.5%) |
Mar 2014 | - | $497.66M(-1822.3%) | $470.50M(-2058.1%) |
Dec 2013 | -$24.03M(-105.4%) | -$28.90M(-36.8%) | -$24.03M(-384.1%) |
Sep 2013 | - | -$45.72M(-196.3%) | $8.46M(-82.6%) |
Jun 2013 | - | $47.46M(+1414.7%) | $48.69M(-89.6%) |
Mar 2013 | - | $3.13M(-12.7%) | $469.89M(+4.8%) |
Dec 2012 | $448.53M(-1455.8%) | $3.59M(-165.4%) | $448.53M(+0.2%) |
Sep 2012 | - | -$5.49M(-101.2%) | $447.74M(+6.7%) |
Jun 2012 | - | $468.65M(-2671.5%) | $419.62M(-968.5%) |
Mar 2012 | - | -$18.23M(-750.7%) | -$48.32M(+46.1%) |
Dec 2011 | -$33.08M(+20.2%) | $2.80M(-108.3%) | -$33.08M(-25.0%) |
Sep 2011 | - | -$33.61M(-4774.8%) | -$44.10M(+196.1%) |
Jun 2011 | - | $719.00K(-124.0%) | -$14.89M(-43.7%) |
Mar 2011 | - | -$2.99M(-63.6%) | -$26.47M(-3.8%) |
Dec 2010 | -$27.53M(-367.8%) | -$8.22M(+86.8%) | -$27.53M(+82.5%) |
Sep 2010 | - | -$4.40M(-59.5%) | -$15.08M(+1621.7%) |
Jun 2010 | - | -$10.86M(+168.2%) | -$876.00K(-108.7%) |
Mar 2010 | - | -$4.05M(-195.9%) | $10.11M(-1.7%) |
Dec 2009 | $10.28M(-84.0%) | $4.22M(-56.9%) | $10.28M(+50.4%) |
Sep 2009 | - | $9.80M(+7620.5%) | $6.83M(-62.5%) |
Jun 2009 | - | $127.00K(-103.3%) | $18.20M(-14.7%) |
Mar 2009 | - | -$3.88M(-599.4%) | $21.33M(-66.7%) |
Dec 2008 | $64.13M(-35.7%) | $776.00K(-96.3%) | $64.13M(-1.3%) |
Sep 2008 | - | $21.17M(+549.7%) | $64.98M(+52.5%) |
Jun 2008 | - | $3.26M(-91.6%) | $42.62M(-69.0%) |
Mar 2008 | - | $38.92M(+2289.4%) | $137.69M(+38.0%) |
Dec 2007 | $99.75M(-14.9%) | $1.63M(-237.2%) | $99.75M(+1.7%) |
Sep 2007 | - | -$1.19M(-101.2%) | $98.12M(-1.2%) |
Jun 2007 | - | $98.32M(+9841.4%) | $99.31M(>+9900.0%) |
Mar 2007 | - | $989.00K | $989.00K |
Dec 2006 | $117.19M(-39.2%) | - | - |
Dec 2005 | $192.85M(+237.4%) | - | - |
Dec 2004 | $57.16M | - | - |
FAQ
- What is Jazz Pharmaceuticals plc annual cash flow from financing activities?
- What is the all time high annual CFF for Jazz Pharmaceuticals plc?
- What is Jazz Pharmaceuticals plc annual CFF year-on-year change?
- What is Jazz Pharmaceuticals plc quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Jazz Pharmaceuticals plc?
- What is Jazz Pharmaceuticals plc quarterly CFF year-on-year change?
- What is Jazz Pharmaceuticals plc TTM cash flow from financing activities?
- What is the all time high TTM CFF for Jazz Pharmaceuticals plc?
- What is Jazz Pharmaceuticals plc TTM CFF year-on-year change?
What is Jazz Pharmaceuticals plc annual cash flow from financing activities?
The current annual CFF of JAZZ is $20.52M
What is the all time high annual CFF for Jazz Pharmaceuticals plc?
Jazz Pharmaceuticals plc all-time high annual cash flow from financing activities is $3.97B
What is Jazz Pharmaceuticals plc annual CFF year-on-year change?
Over the past year, JAZZ annual cash flow from financing activities has changed by +$325.77M (+106.72%)
What is Jazz Pharmaceuticals plc quarterly cash flow from financing activities?
The current quarterly CFF of JAZZ is -$124.53M
What is the all time high quarterly CFF for Jazz Pharmaceuticals plc?
Jazz Pharmaceuticals plc all-time high quarterly cash flow from financing activities is $4.66B
What is Jazz Pharmaceuticals plc quarterly CFF year-on-year change?
Over the past year, JAZZ quarterly cash flow from financing activities has changed by +$36.56M (+22.70%)
What is Jazz Pharmaceuticals plc TTM cash flow from financing activities?
The current TTM CFF of JAZZ is -$699.84M
What is the all time high TTM CFF for Jazz Pharmaceuticals plc?
Jazz Pharmaceuticals plc all-time high TTM cash flow from financing activities is $4.72B
What is Jazz Pharmaceuticals plc TTM CFF year-on-year change?
Over the past year, JAZZ TTM cash flow from financing activities has changed by -$303.40M (-76.53%)